ArticleInternational journal of molecular sciences2019

Hexokinase-II Inhibition Synergistically Augments the Anti-tumor Efficacy of Sorafenib in Hepatocellular Carcinoma.

Jeong-Ju Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.